Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection

Adasme MF, Linnemann KL, Bolz SN, Kaiser F, Salentin S, Haupt VJ, Schroeder M. PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 2021;49(W1):W530–W534. https://doi.org/10.1093/nar/gkab294 Adasme MF Linnemann KL Bolz SN Kaiser F Salentin S Haupt VJ Schroeder M . PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA . Nucleic Acids Res . 2021 ; 49 ( W1 ): W530 – W534 . https://doi.org/10.1093/nar/gkab294 Search in Google Scholar

Anderson SL, Carton JM, Lou J, Xing L, Rubin BY. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology. 1999;256(1):8–14. https://doi.org/10.1006/viro.1999.9614 Anderson SL Carton JM Lou J Xing L Rubin BY . Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus . Virology . 1999 ; 256 ( 1 ): 8 – 14 . https://doi.org/10.1006/viro.1999.9614 Search in Google Scholar

Blanchet M, Sureau C. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity. J Virol. 2006;80(24):11935–11945. https://doi.org/10.1128/JVI.00621-06 Blanchet M Sureau C . Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity . J Virol . 2006 ; 80 ( 24 ): 11935 – 11945 . https://doi.org/10.1128/JVI.00621-06 Search in Google Scholar

Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis. 2007;11(4):685–706. https://doi.org/10.1016/j.cld.2007.08.002 Block TM Guo H Guo JT . Molecular virology of hepatitis B virus for clinicians . Clin Liver Dis . 2007 ; 11 ( 4 ): 685 – 706 . https://doi.org/10.1016/j.cld.2007.08.002 Search in Google Scholar

Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci USA. 1991;88(3):1059–1063. https://doi.org/10.1073/pnas.88.3.1059 Bruss V Ganem D . The role of envelope proteins in hepatitis B virus assembly . Proc Natl Acad Sci USA . 1991 ; 88 ( 3 ): 1059 – 1063 . https://doi.org/10.1073/pnas.88.3.1059 Search in Google Scholar

Dickinson MS, Kutsch M, Sistemich L, Hernandez D, Piro AS, Needham D, Lesser CF, Herrmann C, Coers J. LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro. Proc Natl Acad Sci USA. 2023;120(15):e2216028120. https://doi.org/10.1073/pnas.2216028120 Dickinson MS Kutsch M Sistemich L Hernandez D Piro AS Needham D Lesser CF Herrmann C Coers J . LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro . Proc Natl Acad Sci USA . 2023 ; 120 ( 15 ): e2216028120 . https://doi.org/10.1073/pnas.2216028120 Search in Google Scholar

Du Y, Broering R, Li X, Zhang X, Liu J, Yang D, Lu M. In vivo mouse models for hepatitis B virus infection and their application. Front Immunol. 2021;12:766534. https://doi.org/10.3389/fimmu.2021.766534 Du Y Broering R Li X Zhang X Liu J Yang D Lu M . In vivo mouse models for hepatitis B virus infection and their application . Front Immunol . 2021 ; 12 : 766534 . https://doi.org/10.3389/fimmu.2021.766534 Search in Google Scholar

Feng S, Enosi Tuipulotu D, Pandey A, Jing W, Shen C, Ngo C, Tessema MB, Li FJ, Fox D, Mathur A, et al. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling. Nat Commun. 2022;13(1):4395. https://doi.org/10.1038/s41467-022-32127-0 Feng S EnosiTuipulotu D Pandey A Jing W Shen C Ngo C Tessema MB Li FJ Fox D Mathur A et al. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling . Nat Commun . 2022 ; 13 ( 1 ): 4395 . https://doi.org/10.1038/s41467-022-32127-0 Search in Google Scholar

Fisch D, Bando H, Clough B, Hornung V, Yamamoto M, Shenoy AR, Frickel EM. Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis. EMBO J. 2019;38(13):e100926. https://doi.org/10.15252/embj.2018100926 Fisch D Bando H Clough B Hornung V Yamamoto M Shenoy AR Frickel EM . Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis . EMBO J . 2019 ; 38 ( 13 ): e100926 . https://doi.org/10.15252/embj.2018100926 Search in Google Scholar

Ge GH, Ye Y, Zhou XB, Chen L, He C, Wen DF, Tan YW. Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigennegative chronic hepatitis B patients. World J Gastroenterol. 2015;21(28):8653–8659. https://doi.org/10.3748/wjg.v21.i28.8653 Ge GH Ye Y Zhou XB Chen L He C Wen DF Tan YW . Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigennegative chronic hepatitis B patients . World J Gastroenterol . 2015 ; 21 ( 28 ): 8653 – 8659 . https://doi.org/10.3748/wjg.v21.i28.8653 Search in Google Scholar

Glitscher M, Himmelsbach K, Woytinek K, Schollmeier A, Johne R, Praefcke GJK, Hildt E. Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus. J Virol. 2021;95(7):e01564–20. https://doi.org/10.1128/JVI.01564-20 Glitscher M Himmelsbach K Woytinek K Schollmeier A Johne R Praefcke GJK Hildt E . Identification of the interferon-inducible GTPase GBP1 as major restriction factor for the Hepatitis E virus . J Virol . 2021 ; 95 ( 7 ): e01564 – 20 . https://doi.org/10.1128/JVI.01564-20 Search in Google Scholar

Honkala AT, Tailor D, Malhotra SV. Guanylate-binding protein 1: An emerging target in inflammation and cancer. Front Immunol. 2020;10:3139. https://doi.org/10.3389/fimmu.2019.03139 Honkala AT Tailor D Malhotra SV . Guanylate-binding protein 1: An emerging target in inflammation and cancer . Front Immunol . 2020 ; 10 : 3139 . https://doi.org/10.3389/fimmu.2019.03139 Search in Google Scholar

Huang D, Wu D, Wang P, Wang Y, Yuan W, Hu D, Hu J, Wang Y, Tao R, Xiao F, Zhang X, Wang X, Han M, Luo X, Yan W, Ning Q. End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB. J Hepatol. 2022;77(1):42–54. https://doi.org/10.1016/j.jhep.2022.01.021 Huang D Wu D Wang P Wang Y Yuan W Hu D Hu J Wang Y Tao R Xiao F Zhang X Wang X Han M Luo X Yan W Ning Q . End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB . J Hepatol . 2022 ; 77 ( 1 ): 42 – 54 . https://doi.org/10.1016/j.jhep.2022.01.021 Search in Google Scholar

Islam M, Kumar K, Sevak JK, Jindal A, Vyas AK, Ramakrishna G, Kottilil S, Sharma MK, Sarin SK, Trehanpati N. Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatol Commun. 2023;7(5):e0098. https://doi.org/10.1097/HC9.0000000000000098 Islam M Kumar K Sevak JK Jindal A Vyas AK Ramakrishna G Kottilil S Sharma MK Sarin SK Trehanpati N . Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN . Hepatol Commun . 2023 ; 7 ( 5 ): e0098 . https://doi.org/10.1097/HC9.0000000000000098 Search in Google Scholar

Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology. 2009;50(6):1727–1737. https://doi.org/10.1002/hep.23195 Itsui Y Sakamoto N Kakinuma S Nakagawa M Sekine-Osajima Y Tasaka-Fujita M Nishimura-Sakurai Y Suda G Karakama Y Mishima K et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein . Hepatology . 2009 ; 50 ( 6 ): 1727 – 1737 . https://doi.org/10.1002/hep.23195 Search in Google Scholar

Lebossé F, Testoni B, Fresquet J, Facchetti F, Galmozzi E, Fournier M, Hervieu V, Berthillon P, Berby F, Bordes I, et al. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. J Hepatol. 2017;66(5):897–909. https://doi.org/10.1016/j.jhep.2016.12.024 Lebossé F, Testoni B Fresquet J Facchetti F Galmozzi E Fournier M Hervieu V Berthillon P Berby F Bordes I et al. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B . J Hepatol . 2017 ; 66 ( 5 ): 897 – 909 . https://doi.org/10.1016/j.jhep.2016.12.024 Search in Google Scholar

Li LF, Yu J, Li Y, Wang J, Li S, Zhang L, Xia SL, Yang Q, Wang X, Yu S, et al. Guanylate-binding protein 1, an interferon-induced GTPase, exerts an antiviral activity against classical swine fever virus depending on its GTPase activity. J Virol. 2016;90(9):4412–4426. https://doi.org/10.1128/JVI.02718-15 Li LF Yu J Li Y Wang J Li S Zhang L Xia SL Yang Q Wang X Yu S et al. Guanylate-binding protein 1, an interferon-induced GTPase exerts an antiviral activity against classical swine fever virus depending on its GTPase activity . J Virol . 2016 ; 90 ( 9 ): 4412 – 4426 . https://doi.org/10.1128/JVI.02718-15 Search in Google Scholar

Li P, Jiang W, Yu Q, Liu W, Zhou P, Li J, Xu J, Xu B, Wang F, Shao F. Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence. Nature. 2017;551(7680):378–383. https://doi.org/10.1038/nature24467 Li P Jiang W Yu Q Liu W Zhou P Li J Xu J Xu B Wang F Shao F . Ubiquitination and degradation of GBPs by a Shigella effector to suppress host defence . Nature . 2017 ; 551 ( 7680 ): 378 – 383 . https://doi.org/10.1038/nature24467 Search in Google Scholar

Lin N, Wang L, Guo Z, Guo S, Liu C, Lin J, Wu S, Xu S, Guo H, Fang F, et al. miR-548c-3p targets TRIM22 to attenuate the Peg-IFN-α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B. Antiviral Res. 2023;213:105584. https://doi.org/10.1016/j.antiviral.2023.105584 Lin N Wang L Guo Z Guo S Liu C Lin J Wu S Xu S Guo H Fang F et al. miR-548c-3p targets TRIM22 to attenuate the Peg-IFN-α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B . Antiviral Res . 2023 ; 213 : 105584 . https://doi.org/10.1016/j.antiviral.2023.105584 Search in Google Scholar

Liu J, Wang T, Zhang W, Cheng Y, He Q, Wang FS. Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: A systematic review and meta-analysis. Hepatol Int. 2020;14(6):958–972. https://doi.org/10.1007/s12072-020-10099-x Liu J Wang T Zhang W Cheng Y He Q Wang FS . Effect of combination treatment based on interferon and nucleos(t)ide analogues on functional cure of chronic hepatitis B: A systematic review and meta-analysis . Hepatol Int . 2020 ; 14 ( 6 ): 958 – 972 . https://doi.org/10.1007/s12072-020-10099-x Search in Google Scholar

Mariappan V, Adikari S, Shanmugam L, Easow JM, Balakrishna Pillai A. Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 and GBP2) in severe dengue. Free Radic Biol Med. 2023;194:131–146. https://doi.org/10.1016/j.freeradbiomed.2022.11.037 Mariappan V Adikari S Shanmugam L Easow JM Balakrishna Pillai A . Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 and GBP2) in severe dengue . Free Radic Biol Med . 2023 ; 194 : 131 – 146 . https://doi.org/10.1016/j.freeradbiomed.2022.11.037 Search in Google Scholar

Mirpuri J, Brazil JC, Berardinelli AJ, Nasr TR, Cooper K, Schnoor M, Lin PW, Parkos CA, Louis NA. Commensal Escherichia coli reduces epithelial apoptosis through IFN-αA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine. J Immunol. 2010;184(12):7186–7195. https://doi.org/10.4049/jimmunol.0903116 Mirpuri J Brazil JC Berardinelli AJ Nasr TR Cooper K Schnoor M Lin PW Parkos CA Louis NA . Commensal Escherichia coli reduces epithelial apoptosis through IFN-αA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine . J Immunol . 2010 ; 184 ( 12 ): 7186 – 7195 . https://doi.org/10.4049/jimmunol.0903116 Search in Google Scholar

Mohammadi N, Lindgren H, Golovliov I, Eneslätt K, Yamamoto M, Martin A, Henry T, Sjöstedt A. Guanylate-binding proteins are critical for effective control of Francisella tularensis strains in a mouse co-culture system of adaptive immunity. Front Cell Infect Microbiol. 2020;10:594063. https://doi.org/10.3389/fcimb.2020.594063 Mohammadi N Lindgren H Golovliov I Eneslätt K Yamamoto M Martin A Henry T Sjöstedt A . Guanylate-binding proteins are critical for effective control of Francisella tularensis strains in a mouse co-culture system of adaptive immunity . Front Cell Infect Microbiol . 2020 ; 10 : 594063 . https://doi.org/10.3389/fcimb.2020.594063 Search in Google Scholar

Mutz P, Metz P, Lempp FA, Bender S, Qu B, Schöneweis K, Seitz S, Tu T, Restuccia A, Frankish J, et al. HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon. Gastroenterology. 2018;154(6):1791–1804.e22. https://doi.org/10.1053/j.gastro.2018.01.044 Mutz P Metz P Lempp FA Bender S Qu B Schöneweis K Seitz S Tu T Restuccia A Frankish J et al. HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon . Gastroenterology . 2018 ; 154 ( 6 ): 1791 – 1804 . e22 . https://doi.org/10.1053/j.gastro.2018.01.044 Search in Google Scholar

Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: Advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):e00046-19. https://doi.org/10.1128/CMR.00046-19 Nguyen MH Wong G Gane E Kao JH Dusheiko G . Hepatitis B virus: Advancesin prevention, diagnosis, and therapy . Clin Microbiol Rev . 2020 ; 33 ( 2 ): e00046 – 19 . https://doi.org/10.1128/CMR.00046-19 Search in Google Scholar

Nordmann A, Wixler L, Boergeling Y, Wixler V, Ludwig S. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 2012;26(3):1290–1300. https://doi.org/10.1096/fj.11-189886 Nordmann A Wixler L Boergeling Y Wixler V Ludwig S . A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication . FASEB J . 2012 ; 26 ( 3 ): 1290 – 1300 . https://doi.org/10.1096/fj.11-189886 Search in Google Scholar

Pan W, Zuo X, Feng T, Shi X, Dai J. Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus. Virol J. 2012;9:292. https://doi.org/10.1186/1743-422X-9-292 Pan W Zuo X Feng T Shi X Dai J . Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus . Virol J . 2012 ; 9 : 292 . https://doi.org/10.1186/1743-422X-9-292 Search in Google Scholar

Piratvisuth T, Marcellin P, Popescu M, Kapprell HP, Rothe V, Lu ZM. Hepatitis B surface antigen: Association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients. Hepatol Int. 2013;7(2):429–436. https://doi.org/10.1007/s12072-011-9280-0 Piratvisuth T Marcellin P Popescu M Kapprell HP Rothe V Lu ZM . Hepatitis B surface antigen: Association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients . Hepatol Int . 2013 ; 7 ( 2 ): 429 – 436 . https://doi.org/10.1007/s12072-011-9280-0 Search in Google Scholar

Prakash B, Praefcke GJ, Renault L, Wittinghofer A, Herrmann C. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature. 2000;403(6769):567–571. https://doi.org/10.1038/35000617 Prakash B Praefcke GJ Renault L Wittinghofer A Herrmann C . Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins . Nature . 2000 ; 403 ( 6769 ): 567 – 571 . https://doi.org/10.1038/35000617 Search in Google Scholar

Raninga N, Nayeem SM, Gupta S, Mullick R, Pandita E, Das S, Deep S, Sau AK. Stimulation of GMP formation in hGBP1 is mediated by W79 and its effect on the antiviral activity. FEBS J. 2021;288(9):2970–2988. https://doi.org/10.1111/febs.15611 Raninga N Nayeem SM Gupta S Mullick R Pandita E Das S Deep S Sau AK . Stimulation of GMP formation in hGBP1 is mediated by W79 and its effect on the antiviral activity . FEBS J . 2021 ; 288 ( 9 ): 2970 – 2988 . https://doi.org/10.1111/febs.15611 Search in Google Scholar

Ren JH, Hu JL, Cheng ST, Yu HB, Wong VKW, Law BYK, Yang YF, Huang Y, Liu Y, Chen WX, et al. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3–9 homolog 1 and SET domain containing 1A histone methyltransferases. Hepatology. 2018;68(4):1260–1276. https://doi.org/10.1002/hep.29912 Ren JH Hu JL Cheng ST Yu HB Wong VKW Law BYK Yang YF Huang Y Liu Y Chen WX et al. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3–9 homolog 1 and SET domain containing 1A histone methyltransferases . Hepatology . 2018 ; 68 ( 4 ): 1260 – 1276 . https://doi.org/10.1002/hep.29912 Search in Google Scholar

Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, Pallocca M, Plissonnier ML, Jeddari S, Belloni L, et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69(11):2016–2024. https://doi.org/10.1136/gutjnl-2019-319637 Salerno D Chiodo L Alfano V Floriot O Cottone G Paturel A Pallocca M Plissonnier ML Jeddari S Belloni L et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription . Gut . 2020 ; 69 ( 11 ): 2016 – 2024 . https://doi.org/10.1136/gutjnl-2019-319637 Search in Google Scholar

Santos JC, Boucher D, Schneider LK, Demarco B, Dilucca M, Shkarina K, Heilig R, Chen KW, Lim RYH, Broz P. Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nat Commun. 2020;11(1):3276. https://doi.org/10.1038/s41467-020-16889-z Santos JC Boucher D Schneider LK Demarco B Dilucca M Shkarina K Heilig R Chen KW Lim RYH Broz P . Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria . Nat Commun . 2020 ; 11 ( 1 ): 3276 . https://doi.org/10.1038/s41467-020-16889-z Search in Google Scholar

Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, Rice CM. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472(7344):481–485. https://doi.org/10.1038/nature09907 Schoggins JW Wilson SJ Panis M Murphy MY Jones CT Bieniasz P Rice CM . A diverse range of gene products are effectors of the type I interferon antiviral response . Nature . 2011 ; 472 ( 7344 ): 481 – 485 . https://doi.org/10.1038/nature09907 Search in Google Scholar

Sen GC, Peters GA. Viral stress-inducible genes. Adv Virus Res. 2007;70:233–263. https://doi.org/10.1016/S0065-3527(07)70006-4 Sen GC Peters GA . Viral stress-inducible genes . Adv Virus Res . 2007 ; 70 : 233 – 263 . https://doi.org/10.1016/S0065-3527(07)70006-4 Search in Google Scholar

Shih C, Yang CC, Choijilsuren G, Chang CH, Liou AT. Hepatitis B virus. Trends Microbiol. 2018;26(4):386–387. https://doi.org/10.1016/j.tim.2018.01.009 Shih C Yang CC Choijilsuren G Chang CH Liou AT . Hepatitis B virus . Trends Microbiol . 2018 ; 26 ( 4 ): 386 – 387 . https://doi.org/10.1016/j.tim.2018.01.009 Search in Google Scholar

Suslov A, Boldanova T, Wang X, Wieland S, Heim MH. Hepatitis B virus does not interfere with innate immune responses in the human liver. Gastroenterology. 2018;154(6):1778–1790. https://doi.org/10.1053/j.gastro.2018.01.034 Suslov A Boldanova T Wang X Wieland S Heim MH . Hepatitis B virus does not interfere with innate immune responses in the human liver . Gastroenterology . 2018 ; 154 ( 6 ): 1778 – 1790 . https://doi.org/10.1053/j.gastro.2018.01.034 Search in Google Scholar

Tessema MB, Tuipulotu DE, Oates CV, Brooks AG, Man SM, Londrigan SL, Reading PC. Mouse guanylate-binding protein 1 does not mediate antiviral activity against influenza virus in vitro or in vivo. Immunol Cell Biol. 2023;101(5):383–396. https://doi.org/10.1111/imcb.12627 Tessema MB Tuipulotu DE Oates CV Brooks AG Man SM Londrigan SL Reading PC . Mouse guanylate-binding protein 1 does not mediate antiviral activity against influenza virus in vitro or in vivo . Immunol Cell Biol . 2023 ; 101 ( 5 ): 383 – 396 . https://doi.org/10.1111/imcb.12627 Search in Google Scholar

Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M, Slavin J, Bowden S, Gane EJ, Abbott W, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010;51(6):1933–44. https://doi.org/10.1002/hep.23571 Thompson AJ Nguyen T Iser D Ayres A Jackson K Littlejohn M Slavin J Bowden S Gane EJ Abbott W et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers . Hepatology . 2010 ; 51 ( 6 ): 1933 – 44 . https://doi.org/10.1002/hep.23571 Search in Google Scholar

Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med. 2019;216(3):482–500. https://doi.org/10.1084/jem.20182031 Tretina K Park ES Maminska A MacMicking JD . Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease . J Exp Med . 2019 ; 216 ( 3 ): 482 – 500 . https://doi.org/10.1084/jem.20182031 Search in Google Scholar

Tseng TN, Hu TH, Wang JH, Kuo YH, Hung CH, Lu SN, Jeng WJ, Chen CH. Incidence and factors associated with HBV relapse after cessation of entecavir or tenofovir in patients with HBsAg below 100 IU/ml. Clin Gastroenterol Hepatol. 2020;18(12):2803–2812.e2. https://doi.org/10.1016/j.cgh.2020.04.037 Tseng TN Hu TH Wang JH Kuo YH Hung CH Lu SN Jeng WJ Chen CH . Incidence and factors associated with HBV relapse after cessation of entecavir or tenofovir in patients with HBsAg below 100 IU/ml . Clin Gastroenterol Hepatol . 2020 ; 18 ( 12 ): 2803 – 2812 . e2 . https://doi.org/10.1016/j.cgh.2020.04.037 Search in Google Scholar

Tseng TN, Kuo YH, Hu TH, Hung CH, Wang JH, Lu SN, Chen CH. Kinetics in HBsAg after stopping entecavir or tenofovir in patients with virological relapse but not clinical relapse. Viruses. 2022;14(6):1189. https://doi.org/10.3390/v14061189 Tseng TN Kuo YH Hu TH Hung CH Wang JH Lu SN Chen CH . Kinetics in HBsAg after stopping entecavir or tenofovir in patients with virological relapse but not clinical relapse . Viruses . 2022 ; 14 ( 6 ): 1189 . https://doi.org/10.3390/v14061189 Search in Google Scholar

UniProt Consortium. UniProt: The Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51(D1):D523–D531. https://doi.org/10.1093/nar/gkac1052 UniProt Consortium . UniProt: The Universal Protein Knowledgebase in 2023 . Nucleic Acids Res . 2023 ; 51 ( D1 ): D523 – D531 . https://doi.org/10.1093/nar/gkac1052 Search in Google Scholar

Viganò M, Grossi G, Loglio A, Lampertico P. Treatment of hepatitis B: Is there still a role for interferon? Liver Int. 2018;38(Suppl_1):79–83. https://doi.org/10.1111/liv. 13635 Viganò M, Grossi G Loglio A Lampertico P . Treatment of hepatitis B: Is there still a role for interferon? Liver Int . 2018 ; 38 ( Suppl_1 ): 79 – 83 . https://doi.org/10.1111/liv. 13635 Search in Google Scholar

Wong GLH, Gane E, Lok ASF. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development? J Hepatol. 2022;76(6):1249–1262. https://doi.org/10.1016/j.jhep.2021.11.024 Wong GLH Gane E Lok ASF . How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development? J Hepatol . 2022 ; 76 ( 6 ): 1249 – 1262 . https://doi.org/10.1016/j.jhep.2021.11.024 Search in Google Scholar

Wu D, Wang P, Han M, Chen Y, Chen X, Xia Q, Yan W, Wan X, Zhu C, Xie Q, et al. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: The Endeavor study. Hepatol Int. 2019;13(5):573–586. https://doi.org/10.1007/s12072-019-09956-1 Wu D Wang P Han M Chen Y Chen X Xia Q Yan W Wan X Zhu C Xie Q et al. Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: The Endeavor study . Hepatol Int . 2019 ; 13 ( 5 ): 573 – 586 . https://doi.org/10.1007/s12072-019-09956-1 Search in Google Scholar

Xu S, Huang J, Xun Z, Li S, Fu Y, Lin N, Wu W, Chen T, Liu C, Ou Q. IFIT3 is increased in serum from patients with chronic hepatitis B virus (HBV) infection and promotes the anti-HBV effect of interferon alpha via JAK-STAT2 in vitro. Microbiol Spectr. 2022;10(6):e0155722. https://doi.org/10.1128/spectrum.01557-22 Xu S Huang J Xun Z Li S Fu Y Lin N Wu W Chen T Liu C Ou Q . IFIT3 is increased in serum from patients with chronic hepatitis B virus (HBV) infection and promotes the anti-HBV effect of interferon alpha via JAK-STAT2 in vitro . Microbiol Spectr . 2022 ; 10 ( 6 ): e0155722 . https://doi.org/10.1128/spectrum.01557-22 Search in Google Scholar

Yuen MF, Chen DS, Dusheiko GM, Janssen HLA, Lau DTY, Locarnini SA, Peters MG, Lai CL. Hepatitis B virus infection. Nat Rev Dis Primers. 2018;4:18035. https://doi.org/10.1038/nrdp.2018.35 Yuen MF Chen DS Dusheiko GM Janssen HLA Lau DTY Locarnini SA Peters MG Lai CL . Hepatitis B virus infection . Nat Rev Dis Primers . 2018 ; 4 : 18035 . https://doi.org/10.1038/nrdp.2018.35 Search in Google Scholar

Yuen MF, Heo J, Jang JW, Yoon JH, Kweon YO, Park SJ, Tami Y, You S, Yates P, Tao Y, et al. Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: A phase 2 randomized controlled trial. Nat Med. 2021;27(10):1725–1734. https://doi.org/10.1038/s41591-021-01513-4 Yuen MF Heo J Jang JW Yoon JH Kweon YO Park SJ Tami Y You S Yates P Tao Y et al. Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: A phase 2 randomized controlled trial . Nat Med . 2021 ; 27 ( 10 ): 1725 – 1734 . https://doi.org/10.1038/s41591-021-01513-4 Search in Google Scholar

Yuen MF, Lim SG, Plesniak R, Tsuji K, Janssen HLA, Pojoga C, Gadano A, Popescu CP, Stepanova T, Asselah T, et al.; B-Clear Study Group. Efficacy and safety of bepirovirsen in chronic hepatitis B infection. N Engl J Med. 2022;387(21):1957–1968. https://doi.org/10.1056/NEJMoa2210027 Yuen MF Lim SG Plesniak R Tsuji K Janssen HLA Pojoga C Gadano A Popescu CP Stepanova T Asselah T et al. ; B-Clear Study Group . Efficacy and safety of bepirovirsen in chronic hepatitis B infection. N Engl J Med . 2022 ; 387 ( 21 ): 1957 – 1968 . https://doi.org/10.1056/NEJMoa2210027 Search in Google Scholar

Zhang R, Li Z, Tang YD, Su C, Zheng C. When human guanylate-binding proteins meet viral infections. J Biomed Sci. 2021;28(1):17. https://doi.org/10.1186/s12929-021-00716-8 Zhang R Li Z Tang YD Su C Zheng C . When human guanylate-binding proteins meet viral infections . J Biomed Sci . 2021 ; 28 ( 1 ): 17 . https://doi.org/10.1186/s12929-021-00716-8 Search in Google Scholar